Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy

Published:2015-05-11 Issue:6 Volume:125 Page:2484-2496
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Abravanel Daniel L.,Belka George K.,Pan Tien-chi,Pant Dhruv K.,Collins Meredith A.,Sterner Christopher J.,Chodosh Lewis A.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference88 articles.

1. Global cancer statistics

2. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy

3. Annual hazard rates of recurrence for breast cancer after primary therapy.

4. Dormancy of Mammary Carcinoma After Mastectomy

5. Natural History of More Than 20 Years of Node-Positive Primary Breast Carcinoma Treated With Cyclophosphamide, Methotrexate, and Fluorouracil–Based Adjuvant Chemotherapy: A Study by the Cancer and Leukemia Group B

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer;Neoplasia;2024-11

2. Dormancy and awakening of cancer cells: the extracellular vesicle-mediated cross-talk between Dr. Jekill and Mr. Hyde;Frontiers in Immunology;2024-09-05

3. Prognostic and predictive impact of NOTCH1 in early breast cancer;Breast Cancer Research and Treatment;2024-08-17

4. MAPK14/p38α Shapes the Molecular Landscape of Endometrial Cancer and promotes Tumorigenic Characteristics;2024-06-29

5. Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy;Discover Oncology;2024-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3